Sources

4 Total Sources

GLP-1 Drugs Cut Breast Cancer Risk 30%, Slow Progression in 6 Tumor Types

GLP-1 Drugs Show 30% Cancer Risk Reduction, Slow Progression in Six Tumor Types

FoodNavigator.com2d ago

GLP-1 Drugs May Expand Beyond Weight Loss

Instagram2d ago

GLP-1 Receptor Agonists and Thyroid Cancer Risk Rodent Data and FDA Warning • In rodents, GLP-1 receptor agonists (GLP-1 RAs) stimulate thyroid C-cells, increasing the incidence of medullary thyroid carcinoma (MTC). • Based

Recent research suggests that Ozempic and similar weight-loss medications may be linked to a lower risk of breast cancer, with studies showing about a 30% reduction in incidence among users. These drugs,